1-3 of 3
Xiaochun Yu, MD PhD
Close
Sort by
Journal Articles

Antileukemic Activity of 8-Chloro-Adenosine (8-Cl-Ado) Is Mediated By Mir-155 Degradation and ErbB3 Binding Protein (Ebp1)-Dependent p53 Activation: A Novel Therapeutic Approach for FLT3-ITD Acute Myeloid Leukemia (AML)

Ralf Buettner, PhD, Le Xuan Truong Nguyen, PhD, Bijender Kumar, PhD, Corey James Morales, BA, BS, Chao Liu, PhD, Lisa S Chen, PhD, Tea Pemovska, PhD, Ryan Thompson, BS, Ling Li, PhD, Dinh Hoa Hoang, BS, Bin Zhang, PhD, Lucy Ghoda, PhD, Claudia Kowolik, PhD, Mika Kontro, MD, Krister Wennerberg, PhD, Calum Leitch, PhD, Xiaochun Yu, MD PhD, Ching-Cheng Chen, PhD, David Horne, PhD, Varsha Gandhi, PhD, Vinod A. Pullarkat, MD, Guido Marcucci, Steven T Rosen
Journal: Blood
Blood (2018) 132 (Supplement 1): 3938.
https://doi.org/10.1182/blood-2018-99-119880
Published: 2018
Journal Articles

Novel Therapeutic Targeting of UHRF1 Restores 5'-Azacytidine Response in Resistant Acute Myeloid Leukemia

Anup Kumar Singh, MS, PhD, Xiaochun Yu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1356.
https://doi.org/10.1182/blood-2018-99-115735
Published: 2018
Journal Articles

Activation of SIRT1 Deacetylase As a Therapeutic Approach for Myelodysplastic Syndromes By Restoring TET2 Function

Jie Sun, PhD, Yinghui Zhu, PhD, Xin He, MD, Zonghui Ding, PhD, Haojie DONG, PhD, Yimei Feng, MD PhD, Xiaochun Yu, MD PhD, Dandan Zhao, MD, Herman Wu, BS, Lifeng Feng, PhD, Kaoru Tohyama, MD, Hongchuan Jin, MD PhD, Philipp Oberdoerffer, PhD, Yang Jo Chung, PhD, Peter D. Aplan, MD, Bin Zhang, PhD, Ya-Huei Kuo, PhD, Ravi Bhatia, MD, Andrea Pellagatti, PhD, Jacqueline Boultwood, PhD, Nadia Carlesso, MD PhD, Guido Marcucci, MD, Ling Li, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2497.
https://doi.org/10.1182/blood.V130.Suppl_1.2497.2497
Published: 2017